Back
Kyorin Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Sell
50
KYRNF
Kyorin Pharmaceutical
Last Price:
10.00
Seasonality Move:
0%
Sell
24
SOLTF
Nxera Pharma
Last Price:
6.95
Seasonality Move:
17.77%
Sell
50
Kyorin Pharmaceutical (KYRNF)
is a Sell
Is Kyorin Pharmaceutical a Buy, Sell or Hold?
- The current Kyorin Pharmaceutical [KYRNF] share price is $10.00. The Score for KYRNF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- KYRNF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $6.95. The Score for SOLTF is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYRNF Stock Price Chart
What is Kyorin Pharmaceutical's stock price today?
-
The Kyorin Pharmaceutical share price today is $10.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYRNF is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $6.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
KYRNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10 - 10) | Sell |
Bollinger Bands (100): | (11.26 - 19.52) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 18.38 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.32 - 8.12) | Sell |
Bollinger Bands (100): | (7.61 - 9.71) | Sell |
KYRNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10 | Sell |
20-day SMA: | 10 | Sell |
50-day SMA: | 12.22 | Sell |
200-day SMA: | 16.97 | Sell |
8-day EMA: | 10 | Sell |
20-day EMA: | 10.21 | Sell |
50-day EMA: | 11.95 | Sell |
200-day EMA: | 15.91 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.24 | Sell |
20-day SMA: | 7.66 | Sell |
50-day SMA: | 7.86 | Sell |
200-day SMA: | 9.29 | Sell |
8-day EMA: | 7.22 | Sell |
20-day EMA: | 7.5 | Sell |
50-day EMA: | 7.9 | Sell |
200-day EMA: | 9.13 | Sell |
Kyorin Pharmaceutical Earnings Growth & KYRNF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kyorin Pharmaceutical Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |